Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

VolitionRx appoints new finance head

Tuesday, April 11, 2017 6:49
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Cancer diagnostics group VolitionRx Limited (NYSE MKT:VNRX) has appointed David Vanston as its new chief financial officer with immediate effect. 

Vanston joins from Octo Telematics, a technology company based in Boston, where he was the Senior Controller for its US business.

Before this, he spent 20 years with globally-listed companies in a variety of sectors spanning manufacturing and technology to life sciences .

Cameron Reynolds, Volition’s chief executive, expressed confidence that Vanston would add value as VolitionRx becomes a revenue-generating company.

Former CFO David Kratochvil tendered his resignation in November, but stayed on until a successor was found.


Story by ProactiveInvestors


Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.